Drug Manufacturers - Specialty & Generic

Week ending 29 May 2026 · Index 142.02 · Weekly return 1.22%. Constituents are ranked by weekly return.

Sector Healthcare

Universe all active equity exchanges for the country

Price basis Adjusted weekly close

Index chart

Index Value Trend Line Fair Value Activity Lines

For the week ending 29 May 2026, Drug Manufacturers - Specialty & Generic advanced 1.22% with 8 advancing, 7 declining, and 1 unchanged constituents.

Ticker Company Exchange Open High Low Close Return

BP8 BPH Global Ltd ASX 0.00 0.00 0.00 0.00 33.33%

EXL Elixinol Wellness Limited ASX 0.01 0.01 0.01 0.01 14.29%

PER PERCHERON FPO [PER] ASX 0.00 0.01 0.00 0.00 12.50%

IDT IDT Australia Limited ASX 0.04 0.04 0.04 0.04 8.82%

AFP AFT Pharmaceuticals Limited ASX 3.17 3.24 3.01 3.22 5.57%

RGT Argent BioPharma Limited ASX 0.04 0.04 0.04 0.04 5.26%

EPN Epsilon Healthcare Limited ASX 0.02 0.03 0.02 0.02 4.35%

SNT Syntara Limited ASX 0.03 0.03 0.03 0.03 3.85%

ECS ECS Botanics Holdings Ltd ASX 0.00 0.01 0.00 0.01 0.00%

VIT Vitura Health Limited ASX 0.04 0.04 0.03 0.03 -2.86%

MVP Medical Developments International Limited ASX 0.40 0.43 0.39 0.39 -6.10%

PKP PEAK FPO [PKP] ASX 0.02 0.02 0.01 0.02 -6.25%

VLS Vita Life Sciences Limited ASX 2.56 2.56 2.38 2.40 -6.25%

LGP Little Green Pharma Ltd ASX 0.10 0.10 0.09 0.09 -8.42%

IVX Invion Limited ASX 0.05 0.05 0.04 0.04 -10.20%

CAN Cann Group Limited ASX 0.01 0.01 0.00 0.00 -20.00%